BUY Granules IndiaOsho Krishan, Angel One

byOsho Krishan, Angel OneHorizon: 1–3 months30 Jun 2026via ET Now

Entry₹817.65Inferred
Target₹860
Total upside +5.18% (call closed)
Stop lossNot given
Exit₹8606 Jul 2026, 12:07 pm
Target hit+5.18%0.00%upside left

Not investment advice; past performance doesn't guarantee future results. · Public beta — data is auto-extracted and may contain errors.

AI Assessment

Automated market context for this BUY call — facts from public sources, machine-classified. Not investment advice.

As of 8 Sept, 7:34 pm IST
4 supporting0 opposing
Supports the BUY call (4)

Granules India Limited has secured sole first-to-file ANDA status for Sodium Oxybate Extended-Release for Oral Suspension.

NSE · Press Release·6 Jul · today

(opens in new tab)

1 advisor has an active swing BUY call on this stock, issued in the last 14 days

Advisor consensus · adjacent horizon·29 Jun · 6d ago

Neutral / worth noting (0)

Nothing found in this tip’s window yet.

Weighs against the BUY call (0)

Nothing found in this tip’s window yet.

Factor classifications are AI-generated from exchange filings, verified news feeds and market data — they can be wrong or incomplete, and are not attributed to the issuing analyst. Verify every factor via its linked original before acting. This is not investment advice.

StockTipsArena© 2026 · NSE equities only · Not investment advicePublic beta · data is auto-aggregated from public sources and may contain errors — verify before acting.